Lexaria Bioscience (LEXX) Stock Chart & Stock Price History $0.96 -0.02 (-2.04%) Closing price 05/21/2025 04:00 PM EasternExtended Trading$0.96 +0.01 (+0.52%) As of 05/21/2025 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Lexaria Bioscience Stock Price Performance The Lexaria Bioscience (LEXX) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 65.09%, with a year-to-date return of -54.29%. In the past month, the stock has decreased 34.25%, reflecting recent market activity. As of the latest close, Lexaria Bioscience traded at $0.96 with a market cap of $16.86 million and volume of 61,560 shares. Receive LEXX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Lexaria Bioscience and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-4.95%1 Month Performance-34.25%3 Month Performance-33.79%Year-To-Date Performance-54.29%1 Year Performance-65.09% LEXX Stock Chart for Thursday, May, 22, 2025 LEXX Chart by TradingView Lexaria Bioscience Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/21/2025$0.98$0.96-2.04%$1.01$0.9561,560 shs$16.86 million05/20/2025$1.00$0.98-2.00%$1.02$0.9741,461 shs$17.21 million05/19/2025$1.01$1.00-0.99%$1.02$0.9598,527 shs$17.56 million05/16/2025$1.03$1.01-1.94%$1.03$1.0082,916 shs$17.74 million05/15/2025$1.06$1.03-2.83%$1.05$1.0258,186 shs$18.09 million05/14/2025$1.07$1.06-0.93%$1.08$1.0551,337 shs$18.61 million05/13/2025$1.08$1.07-0.47%$1.09$1.0570,479 shs$18.79 million05/12/2025$1.08$1.08-0.46%$1.12$1.06128,246 shs$18.88 million05/09/2025$1.06$1.08+1.89%$1.10$1.0494,586 shs$18.96 million05/08/2025$1.04$1.06+1.92%$1.08$1.01161,506 shs$18.61 million Get the Latest News and Ratings for LEXX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Lexaria Bioscience and its competitors with MarketBeat's FREE daily newsletter. 05/07/2025$1.08$1.04-3.70%$1.09$1.0281,824 shs$18.26 million05/06/2025$1.14$1.08-5.26%$1.14$1.0495,383 shs$18.96 million05/05/2025$1.19$1.14-4.20%$1.17$1.11123,529 shs$20.02 million05/02/2025$1.23$1.19-3.25%$1.23$1.19127,515 shs$20.90 million05/01/2025$1.16$1.23+6.03%$1.23$1.16133,483 shs$21.60 million04/30/2025$1.17$1.16-0.85%$1.19$1.1446,430 shs$20.37 million04/29/2025$1.22$1.17-4.10%$1.24$1.1690,791 shs$20.54 million04/28/2025$1.35$1.22-9.63%$1.28$1.22129,329 shs$21.42 million04/25/2025$1.69$1.35-20.12%$1.45$1.23600,311 shs$29.68 million04/24/2025$1.59$1.69+6.29%$1.69$1.5259,107 shs$29.68 million04/23/2025$1.46$1.59+8.90%$1.65$1.41124,230 shs$27.92 million04/22/2025$1.39$1.46+5.04%$1.47$1.3919,134 shs$25.64 million04/21/2025$1.38$1.39+0.72%$1.44$1.3426,676 shs$24.41 million Related Companies GNTA Stock Chart XCUR Stock Chart CTMX Stock Chart TELO Stock Chart EPIX Stock Chart STRO Stock Chart PYXS Stock Chart JSPR Stock Chart IGMS Stock Chart MNOV Stock Chart Receive LEXX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Lexaria Bioscience and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:LEXX) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredA new financial chapter Porter Stansberry says what happened last week could become the defining legacy of his financial publishing ca...Porter & Company | SponsoredThe Secret Map of America, Declassified…Locked inside a Maryland man’s private safe is a map. But not just any map, mind you… This map shows a “...Banyan Hill Publishing | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredElon’s backup plan for AIElon knows the future isn’t about smarter AI — it’s about powering it. And this new technology is quietly b...True Market Insiders | SponsoredExclusive Offer: Target 100% Returns NowBrace yourself–this may come as a shock. It turns out that you may not have to wait decades to turn a small...ProsperityPub | SponsoredPrepare now for May 31 eventPrepare now for May 31 event Circle May 31 on your calendar This man grew up in a trailer in New Mexico. To...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lexaria Bioscience Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Lexaria Bioscience With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.